Shanghai Institute of Materia Medica, Chinese Academy of Sciences

China

Create a watch for Shanghai Institute of Materia Medica, Chinese Academy of Sciences
Total IP 849
Total IP Rank # 1,604
IP Activity Score 3.5/5.0    516
IP Activity Rank # 1,363

Patents

Trademarks

162 0
69 0
618 0
0
 
Last Patent 2025 - 1,2,3-triazole derivatives as il...
First Patent 1995 - Huperzine a derivatives, their p...

Latest Inventions, Goods, Services

2025 Invention Paeoniflorin monohydrate crystal form a, preparation method therefor, and use thereof. The inven...
Invention Conjugate using succinyl as linker, and preparation method therefor and use thereof. Disclosed in...
Invention 1,2,3-triazole derivatives as il4i1 inhibitors. The invention relates to compounds of Formula (I)...
Invention Compound for degrading usp7 protein by means of targeted ubiquitination, pharmaceutical compositi...
Invention Glycopeptide targeting tumor-related fibroblast activation protein, radionuclide marker and use t...
Invention Macrocyclic derivatives and use thereof. The present disclosure relates to a macrocyclic RAS inhi...
Invention Morphinan compounds, preparation method therefor, and use thereof. The present invention relates ...
Invention Nitrogen-containing heterocyclic compound and use thereof. Disclosed in the present invention are...
Invention Compound for treating connective tissue diseases, and pharmaceutical composition comprising same....
Invention Bidirectional cyclic peptide dna-encoded compound, and library construction method therefor and u...
Invention Yohimbine derivative, and preparation method therefor and pharmaceutical composition and use ther...
Invention Substituted phenyl-containing amine compound, and preparation method therefor and use thereof. Di...
Invention Protein degradation agent conjugate and conjugate thereof. A protein degradation agent conjugate ...
Invention Quinazolinone-fused five-membered heterocyclic compound, pharmaceutical composition thereof, and ...
Invention Pyrazolo[3,4-d]pyridazinone compound, preparation method therefor, pharmaceutical composition the...
Invention Lycium barbarum polysaccharide peptide, preparation method therefor and use thereof. 44-induced c...
Invention Melanoma-targeted radiopharmaceutical, and preparation therefor and use thereof. The present inve...
Invention Oxazolone-substituted pyrimidinamine compound, preparation method therefor, pharmaceutical compos...
Invention Transcriptional enhanced associate domains (teads) inhibitor compound, and pharmaceutical composi...
Invention Medicament for treating brain diseases. The present disclosure provides a medicament for treating...
Invention Trop2-targeted antibody-drug conjugate, and preparation method therefor and use thereof. Disclose...
Invention Fto inhibitors, preparation method therefor and use thereof. Provided in the present invention ar...
Invention Spiro compound, pharmaceutical composition containing same and use thereof. Disclosed in the pres...
Invention Antiviral heterocyclic scaffold derivative, preparation method therefor, pharmaceutical combinati...
Invention Quinolinium-based fap inhibitor, and preparation method therefor and use thereof. Provided in the...
Invention Use of bougainvillea glabra triterpenoid saponin compound. Provided is use of a Bougainvillea gla...
2024 Invention Squaric acid compound, pharmaceutically acceptable salt or deuterated compound thereof, preparati...
Invention Use of 1-(3-aminopropyl) substituted cyclic amine compound. The present invention relates to phar...
Invention Molecular image probe targeting poly adp ribose polymerase, and preparation method and use theref...
Invention Mitochondria-targeting probe, preparation method therefor, and application thereof. A mitochondri...
Invention Use of chemokine receptor 2 antagonist in preparation of treatment of anxiety disorders associate...
Invention Purine compound and use thereof. Provided are a purine compound and the use thereof. The purine c...
Invention Pyrazolotriazine and pyrazolopyrimidine derivatives, preparation method therefor, pharmaceutical ...
Invention Endoglycosidase s2 mutant, preparation method therefor and use thereof in antibody glycosylation ...
Invention Disaccharide-acylhydrazone or disaccharide-hydrazide linker, glyco-engineered antibody and sugar-...
2023 Invention Use of targeted inhibition of p300/cbp in treating liver injury diseases. Use of targeted inhibit...
Invention Alpha, beta-unsaturated amide compound, and preparation method therefor, and pharmaceutical compo...
Invention Substituted 4-aminoisoindoline compound, preparation method therefor, pharmaceutical composition ...
Invention Tetrahydroisoquinoline compound, preparation method therefor, pharmaceutical composition containi...
Invention Antiviral nucleoside analogue, and pharmaceutical composition and use thereof. The present inven...
Invention Isoquinolinone compound, and preparation method and use therefor. Provided are an isoquinolinone...
Invention Preparation and anti-tumor application of gene therapy vector interfering cklf-like marvel transm...
Invention Cleavable fragment directed by affinity fragment, design and synthesis thereof, and use thereof i...
Invention Salt of substituted amino six-membered nitric heterocyclic compound, crystal form thereof, method...
Invention Anti-human pd-ll and tlr7 double-targeting nanobody conjugate drug and use thereof in resisting t...
Invention Cyclic(alkyl)(amino)alkoxy-substituted aryl-pyrone compound and use thereof. A novel compound re...
Invention High-selectivity kcnq4 potassium channel agonist, preparation method therefor and use thereof. D...
2022 Invention Cyclic bisbenzyl tetrahydroisoquinoline compound, and preparation method therefor and use thereof...
Invention Sulfonylurea compound, preparation method therefor, and application thereof. The present inventi...
2021 Invention Compound for treating thrombotic diseases. The present invention relates to a compound for treat...